The market has soared to begin 2013 with many biotech companies leading the way. That should be no surprise given the massive swings that companies can make in just a week's time. Fortunately for some lucky investors, several biotech stocks have absolutely destroyed the returns of the broader market. In the following video, Fool contributor Maxx Chatsko reviews the five hottest biotech stocks through the first five months of the year and tells investors if things are about to cool down any time soon.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
5 Best Biotechs of 2013
NASDAQ: MNKD
MannKind

A simple list of five of the hottest biotech stocks through May.
Fool contributor Maxx Chatsko has no position in any stocks mentioned. The Motley Fool recommends Vertex Pharmaceuticals. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned




*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.